-
Start Preamble
ACTION:
Notice of registration.
SUMMARY:
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices are listed in the table below. No comments or objections were submitted and no requests for hearings were submitted for these notices.
Company FR Docket Published Chattem Chemicals, Inc 83 FR 39129 August 8, 2018. Myoderm 83 FR 39130 August 8, 2018. Mylan Pharmaceuticals, Inc 83 FR 22517 May 15, 2018. Anderson Brecon, Inc 83 FR 39128 August 8, 2018. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.
Start SignatureDated: October 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22830 Filed 10-18-18; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 10/19/2018
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of registration.
- Document Number:
- 2018-22830
- Pages:
- 53107-53107 (1 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2018-22830.pdf